FGH Biotech, Inc.
Pharmaceutical company · Houston, Texas, United States
FGH Biotech, Inc. is a pharmaceutical company headquartered in Houston, Texas, United States. Its earliest recorded incorporation is in 2011. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $1.8 million in total, most recently in 2014. It has reported private securities offerings to the US SEC, most recently $2.1 million sold in a notice filed in 2018.
FGH Biotech at a glance
What does FGH Biotech do?
US government research funding
2 SBIR/STTR small-business research awards from US health agencies, $1.8 million in total (2012 to 2014).
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $2.1 million sold (2018).
Frequently asked questions about FGH Biotech
Where is FGH Biotech headquartered?
FGH Biotech, Inc. is headquartered in Houston, Texas, United States.
What does FGH Biotech do?
FGH Biotech, Inc. is a pharmaceutical company.
When was FGH Biotech founded?
The earliest incorporation on record for FGH Biotech, Inc. is in 2011, according to public company registers.
Similar companies
- Marker Therapeutics, Inc.Houston, Texas, United States
- 7 Hills Pharma Inc.Houston, Texas, United States
- Decoy Therapeutics Inc.Houston, Texas, United States
- CNS Pharmaceuticals, Inc.Houston, Texas, United States
- Coya Therapeutics, Inc.Houston, Texas, United States
- Aravive, Inc.Houston, Texas, United States
- Beta Cat Pharmaceuticals, Inc.Houston, Texas, United States
- Moleculin Biotech, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences